Details

Autor(en) / Beteiligte

• Roc, Lourdes
• de Mendoza, Carmen
• Fernández-Alonso, Miriam
• Reina, Gabriel
• Soriano, Vicente
• Rodríguez, C.
• Vera, M.
• Marcaida, G.
• Ocete, M.D.
• Caballero, E.
• Molina, I.
• Aguilera, A.
• Rodríguez-Calviño, J.J.
• Navarro, D.
• Rivero, C.
• Vilariño, M.D.
• Benito, R.
• Algarate, S.
• Gil, J.
• Ortiz de Lejarazu, R.
• Rojo, S.
• Eirós, J.M.
• San Miguel, A.
• Manzardo, C.
• Miró, J.M.
• García, J.
• Paz, I.
• Poveda, E.
• Calderón, E.
• Escudero, D.
• Trigo, M.
• Diz, J.
• García-Campello, M.
• Rodríguez-Iglesias, M.
• Hernández-Betancor, A.
• Martín, A.M.
• Ramos, J.M.
• Gimeno, A.
• Gutiérrez, F.
• Rodríguez, J.C.
• Sánchez, V.
• Gómez-Hernando, C.
• Cilla, G.
• Pérez-Trallero, E.
• López-Aldeguer, J.
• Fernández-Pereira, L.
• Niubó, J.
• Hernández, M.
• López-Lirola, A.M.
• Gómez-Sirvent, J.L.
• Force, L.
• Cifuentes, C.
• Pérez, S.
• Morano, L.
• Raya, C.
• González-Praetorius, A.
• Pérez, J.L.
• Peñaranda, M.
• Hernáez-Crespo, S.
• Montejo, J.M.
• Roc, L.
• Martínez-Sapiña, A.
• Viciana, I.
• Cabezas, T.
• Lozano, A.
• Fernández, J.M.
• García-Bermejo, I.
• Gaspar, G.
• García, R.
• Górgolas, M.
• Vegas, C.
• Blas, J.
• Miralles, P.
• Valeiro, M.
• Aldamiz, T.
• Margall, N.
• Guardia, C.
• do Pico, E.
• Polo, I.
• Aguinaga, A.
• Ezpeleta, C.
• Sauleda, S.
• Pirón, M.
• González, R.
• Jiménez, A.
• Blanco, L.
• Suárez, A.
• Rodríguez-Avial, I.
• Parra, P.
• Fernández, M.
• Fernández-Alonso, M.
• Reina, G.
• Treviño, A.
• Requena, S.
• Benítez-Gutiérrez, L.
• de Mendoza, C.
• Barreiro, P.
• Soriano, V.
• Corral, O.
• Gómez-Gallego, F.

Titel

Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals

Ist Teil von

• Therapeutic advances in infectious disease, 2019, Vol.6, p.204993611986802

Ort / Verlag

London, England: SAGE Publications

Erscheinungsjahr

2019

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Two kidney transplant recipients from a single donor became infected with HTLV-1 (human T-lymphotropic virus type 1) in Spain. One developed myelopathy 8 months following surgery despite early prescription of antiretroviral therapy. The allograft was removed from the second recipient at month 8 due to rejection and immunosuppressors discontinued. To date, 3 years later, this patient remains infected but asymptomatic. HTLV-1 infection was recognized retrospectively in the donor, a native Spaniard who had sex partners from endemic regions. Our findings call for a reappraisal of screening policies on donor–recipient organ transplantation. Based on the high risk of disease development and the large flux of persons from HTLV-1 endemic regions, pre-transplant HTLV-1 testing should be mandatory in Spain.